Skip to main content

EBV-Positive DLBCL clinical trials at UCSF

1 research study open to eligible people

EBV-Positive DLBCL is a type of lymphoma. There's a clinical trial at UCSF for patients with relapsed/refractory lymphomas caused by the Epstein-Barr virus. The trial is testing a combination of nanatinostat and valganciclovir.

Showing trials for

Last updated: